Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.
The histological demonstration of beta 2-microglobulin (B2M) amyloidosis in a 75-year-old man treated exclusively by continuous ambulatory peritoneal dialysis (CAPD) for 87 months is reported. Amyloid deposits were detected in all joints from which synovial specimens were obtained at autopsy. It is of note that the patient had never undergone hemodialysis and had suffered only one episode of peritonitis. Both features are of interest, as the few reports of dialysis-related amyloidosis (DRA) in CAPD include patients who have been hemodialyzed and have suffered repeated episodes of peritonitis, both conditions being incriminated in the genesis of B2M amyloidosis. We conclude that DRA may develop in the absence of artificial membranes or frequent peritonitis episodes.
Jadoul
M
M
Department of Nephrology, University of Louvain Medical School, Cliniques Universitaires St-Luc, Brussels, Belgium.
Noel
H
H
van Ypersele de Strihou
C
C
D000368:Aged; D000686:Amyloidosis / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D013583:Synovial Membrane / Q000378:metabolism; D001613:beta 2-Microglobulin / Q000032:analysis*
D001613:beta 2-Microglobulin